SCHEMBL2987235

SCHEMBL2987235

C=CCC(N)(C(=O)OC)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.53
ALDH1A1 P00352 3/20 0.51
KCNN4 O15554 1/20 0.51
TSHR P16473 1/20 0.51
KMT2A Q03164 4/20 0.46
MEN1 O00255 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 3/20 0.44
SRC P12931 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
CYP2C19 P33261 2/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
GAA P10253 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27630546 0.87 KCNN4 (0.51) HTTALDH1A1KCNN4TSHRKMT2A
SCHEMBL3617442 0.84 HTT (0.50) HTTALDH1A1TSHRKMT2AMEN1
SCHEMBL3617440 0.84 HTT (0.50) HTTALDH1A1TSHRKMT2AMEN1
SCHEMBL3999764 0.82 ALDH1A1 (0.67) HTTALDH1A1KCNN4TSHRKMT2A
SCHEMBL4015143 0.82 KCNN4 (0.53) HTTALDH1A1KCNN4TSHRKMT2A
SCHEMBL3593284 0.82 KCNN4 (0.53) HTTALDH1A1KCNN4TSHRKMT2A
SCHEMBL14231962 0.81 KCNN4 (0.56) KCNN4TSHRKMT2AMEN1MAPT
SCHEMBL26985796 0.81 KCNN4 (0.56) ALDH1A1KCNN4KMT2AMEN1MAPT
SCHEMBL6324059 0.81 KCNN4 (0.56) KCNN4TSHRKMT2AMEN1MAPT
SCHEMBL1908316 0.81 ALDH1A1 (0.65) HTTALDH1A1KCNN4TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786163-B2 Constrained cyano compounds Forest Laboratories Holdings Limited (BM) 2010-08-31 US disclosed
US-7786163-B2 Constrained cyano compounds Forest Laboratories Holdings Limited (BM) 2010-08-31 US disclosed
US-7786163-B2 Constrained cyano compounds Forest Laboratories Holdings Limited (BM) 2010-08-31 US disclosed
EP-1778220-A1 CONSTRAINED CYANO COMPOUNDS Phenomix Corporation (US) 2007-05-02 EP disclosed
WO-2006017292-A1 CONSTRAINED CYANO COMPOUNDS PHENOMIX CORPORATION (US) 2006-02-16 WO disclosed
WO-2006017292-A1 CONSTRAINED CYANO COMPOUNDS PHENOMIX CORPORATION (US) 2006-02-16 WO disclosed
US-20060009518-A1 Constrained cyano compounds Forest Laboratories Holding Limited (BM) 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009518-A1 Constrained cyano compounds DNPEP, PREP, PEPD HTT 3938/4885ALDH1A1 3608/4885KCNN4 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.